<DOC>
	<DOCNO>NCT02551107</DOCNO>
	<brief_summary>This pilot study aim measure nasal nitric oxide ( nNO ) group neonates infant ( â‰¤ 12 month ) congenital heart disease ( CHD ) compare nNO level age match control without CHD . CHD patient divide subgroup , base cardiac anatomy , try identify level risk ciliary dyskinesia within subgroup CHD . Each sub group ' nNO level compare group age match control infant without CHD .</brief_summary>
	<brief_title>Infant Nasal Nitric Oxide Levels Congenital Heart Disease</brief_title>
	<detailed_description>Methods : Parents legal guardian approach provide write , informed consent . To allow least three sub group cardiac anomaly ( 20 patient per group ) , 60 child , less one year age , CHD recruit Pediatric Cardiology inpatient ward Stollery Children 's Hospital . Sixty age match control , without acute respiratory illness , recruit General Pediatric inpatient ward . All subject breathe room air time nNO measurement . Subjects : This pilot study gather data power future study . The investigator aim recruit 60 subject CHD 60 normal control without CHD . 60 subject allow least three sub group cardiac anomaly 20 subject per group . Control group : The control group consist age match infant , less one year age , without CHD acute respiratory illness . They also require write informed consent breathing room air time nNO test . Investigational device : For nNO assessment , inert nitric oxide ( NO ) sample line disposable foam olive ( DirectMed Inc. , Glen Cove , NY ) place one subject 's nostrils contralateral nostril leave open . Air sample constant rate 0.3 Liters/min nose chemiluminescent analyzer provide measurement nNO level part per billion ( ppb ) . All nNO measurement perform subject supine . Measurements obtain use NO analyzer ( CLD 88 SP , ECO PHYSICS AG , Duerten , Switzerland ) available Stollery Children 's Hospital . The analyzer calibrate accord manufacturer 's specification . Two sample take five minute apart , assess test-retest reproducibility , result patient average two sample . The test painful sample take less minute .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>All patient , less one year age , CHD eligible study exception patient patent foramen ovale ( PFO ) patent ductus arteriosus ( PDA ) . The diagnosis CHD confirm echocardiography . All patient , less one year age , CHD eligible study exception patient patent foramen ovale ( PFO ) patent ductus arteriosus ( PDA ) . The diagnosis CHD confirm echocardiography . Control group : The control group consist age match infant , less one year age , without CHD acute respiratory illness . They also require write informed consent breathing room air time nNO test .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>